Nicola Beltraminelli
Corporate Officer/Principal chez INNATE PHARMA
Fortune : 25 395 $ au 31/05/2024
Profil
Nicola Beltraminelli is currently the Director at Mabdesign Association and the Chief Development Officer & Vice President at Innate Pharma SA. Previously, he worked as the Chief Technical Officer at Lysogene SA. He holds a doctorate degree from the University of Lausanne.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INNATE PHARMA SA CLASS A
0,01% | 31/12/2023 | 9 246 ( 0,01% ) | 25 395 $ | 31/05/2024 |
Postes actifs de Nicola Beltraminelli
| Sociétés | Poste | Début |
|---|---|---|
| INNATE PHARMA | Corporate Officer/Principal | 01/01/2022 |
Mabdesign Association
 Mabdesign Association Miscellaneous Commercial ServicesCommercial Services MabDesign Association is a French biotherapy industry association that aims to structure the biopharmaceutical industry from its R&D phases to biomanufacturing and marketing. The private company is based in Lyon, France and was founded in 2014. The association offers services to help companies strengthen their competitiveness and implement a solid intellectual property strategy. MabDesign's board of directors is composed of a pharmaceutical industry college and a competitiveness cluster college. The CEO is Nicolas Groux. | Directeur/Membre du Conseil | - |
Anciens postes connus de Nicola Beltraminelli
| Sociétés | Poste | Fin |
|---|---|---|
| LYSOGENE | Directeur Technique/Scientifique/R&D | - |
Formation de Nicola Beltraminelli
| University of Lausanne | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INNATE PHARMA | Health Technology |
| LYSOGENE | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Mabdesign Association
Mabdesign Association Miscellaneous Commercial ServicesCommercial Services MabDesign Association is a French biotherapy industry association that aims to structure the biopharmaceutical industry from its R&D phases to biomanufacturing and marketing. The private company is based in Lyon, France and was founded in 2014. The association offers services to help companies strengthen their competitiveness and implement a solid intellectual property strategy. MabDesign's board of directors is composed of a pharmaceutical industry college and a competitiveness cluster college. The CEO is Nicolas Groux. | Commercial Services |
